Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to September 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $2.0B |
| Sales growthchange from the year before | +15.9% |
| Gross marginshare of sales left after the direct cost of what it sells | 82.2% |
| Operating marginshare of sales left after running the business | 46.5% |
| Net marginshare of sales kept as profit | 32.7% |
| Free-cash-flow marginspare cash generated per $100 of sales | 38.7% |
| Return on equityprofit vs. shareholders' accounting value | n/m |
| Debt / equitydebt vs. shareholders' accounting value | n/m |
| Change in share countnegative = the company is buying back its shares | -2.1% |
1 insider sold $1.4M (all under pre-arranged plans) on the open market.
| Manolis EvaDirector | Sold (plan)Jul 29 | 967 shat $1400.00 · $1.4M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy